The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VICTOR: Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)—A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK.
 
Syed A. Hussain
Honoraria - Bayer Schering Pharma; Pierre Fabre
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Pierre Fabre
Research Funding - Bayer Schering Pharma (Inst); Boehringer Ingelheim (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Boehringer Ingelheim; Janssen-Cilag
 
Jawaher Ansari
No Relationships to Disclose
 
Robert Anthony Huddart
Leadership - Cancer clinic london Limited liability partnership
Honoraria - Janssen Oncology
Speakers' Bureau - AstraZeneca; Pierre Fabre
Research Funding - Active Biotech; Ipsen
Travel, Accommodations, Expenses - Janssen Oncology
 
James Wylie
No Relationships to Disclose
 
Maria Vilarino-Varela
No Relationships to Disclose
 
Guy Faust
No Relationships to Disclose
 
Melissa Tan
No Relationships to Disclose
 
Jeanette Lyons
No Relationships to Disclose
 
Alison Hassall
No Relationships to Disclose
 
Carlos Escriu
No Relationships to Disclose
 
Seema Chauhan
No Relationships to Disclose
 
Richard Jackson
No Relationships to Disclose